Samady Habib, Wackers Frans J Th, Joska Tammy M, Zaret Barry L, Jain Diwakar
Division of Cardiovascular Medicine, University of Virginia Health Systems, Charlottesville, Va, USA.
J Nucl Cardiol. 2002 Mar-Apr;9(2):188-96. doi: 10.1067/mnc.2002.119973.
Adenosine is commonly used for pharmacologic stress myocardial perfusion imaging (MPI). However, it frequently results in adverse effects, and the subdiaphragmatic tracer uptake may interfere with the image interpretation. Our aim was to determine the feasibility of combining low-level treadmill exercise with adenosine MPI and its impact on adverse effects, image quality, and myocardial ischemia.
Forty-one patients underwent technetium 99m sestamibi single photon emission computed tomography following adenosine and adenosine with low-level exercise (adenosine-Ex) on separate occasions and rest MPI. A comparison was made of symptoms, hemodynamic response, electrocardiographic changes, image quality, and image interpretation between the 2 protocols. With adenosine-Ex, fewer patients had one or more adverse effects (61% vs 90%; P =.006), more patients had ischemic electrocardiographic changes (34% vs 15%; P =.03), a higher percentage had excellent- or fair-quality images (88% vs 61%; P =.003), and they had higher heart-liver ratios (1.0 +/- 0.37 vs 0.84 +/- 0.29; P =.002) compared with adenosine alone. Four adenosine MPI studies, but only 2 adenosine-Ex studies, were uninterpretable because of excessive subdiaphragmatic radiotracer activity. Of the 39 patients with at least 1 interpretable stress study, interpretation was discordant in 11 (28%): 7 showed greater ischemia with adenosine-Ex, 2 uninterpretable adenosine studies were interpretable with adenosine-Ex, and 2 studies interpreted as abnormal with adenosine were normal by adenosine-Ex (both had normal coronary angiograms).
Simultaneous low-level treadmill exercise with adenosine Tc-99m sestamibi imaging is safe and feasible, significantly reduces unfavorable side effects, enhances image quality, and may result in greater ischemia detection compared with adenosine alone.
腺苷常用于药物负荷心肌灌注成像(MPI)。然而,它经常会导致不良反应,并且膈下示踪剂摄取可能会干扰图像解读。我们的目的是确定低水平平板运动与腺苷MPI联合应用的可行性及其对不良反应、图像质量和心肌缺血的影响。
41例患者分别在接受腺苷、腺苷联合低水平运动(腺苷 - 运动组)后以及静息MPI时接受锝99m甲氧基异丁基异腈单光子发射计算机断层扫描。对两种方案的症状、血流动力学反应、心电图变化、图像质量和图像解读进行了比较。与单独使用腺苷相比,腺苷 - 运动组出现一种或多种不良反应的患者更少(61% 对90%;P = 0.006),出现缺血性心电图变化的患者更多(34% 对15%;P = 0.03),图像质量为优或良的百分比更高(88% 对61%;P = 0.003),并且心肝比值更高(1.0±0.37对0.84±0.29;P = 0.002)。由于膈下放射性示踪剂活性过高,4例腺苷MPI研究无法解读,但腺苷 - 运动组只有2例无法解读。在39例至少有1次可解读的负荷研究的患者中,11例(28%)的解读不一致:7例在腺苷 - 运动组显示出更严重的缺血,2例无法解读的腺苷研究在腺苷 - 运动组可解读,2例腺苷研究被解读为异常而腺苷 - 运动组为正常(两者冠状动脉造影均正常)。
腺苷与锝99m甲氧基异丁基异腈成像同时进行低水平平板运动是安全可行的,与单独使用腺苷相比,可显著减少不良副作用,提高图像质量,并可能导致更多的缺血检测。